Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification.
Brum da Silva Nunes V, Kehl Dias C, Nathali Scholl J, Nedel Sant'Ana A, de Fraga Dias A, Granero Farias M, Alegretti AP, Sosnoski M, Esteves Daudt L, Bohns Michalowski M, Oliveira Battastini AM, Paz AA, Figueiró F. Brum da Silva Nunes V, et al. Among authors: de fraga dias a. Discov Oncol. 2022 Dec 30;13(1):143. doi: 10.1007/s12672-022-00602-1. Discov Oncol. 2022. PMID: 36581667 Free PMC article.
P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells.
Vargas P, Scheffel TB, Diz FM, Rockenbach L, Grave N, Cappellari AR, Kist LW, Bogo MR, Thomé MP, Leal GF, de Fraga Dias A, Figueiró F, Filippi-Chiela EC, Lenz G, Morrone FB. Vargas P, et al. Among authors: de fraga dias a. Purinergic Signal. 2022 Dec;18(4):481-494. doi: 10.1007/s11302-022-09888-w. Epub 2022 Aug 8. Purinergic Signal. 2022. PMID: 35939198 Free PMC article.
Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.
Bruinsmann FA, de Cristo Soares Alves A, de Fraga Dias A, Lopes Silva LF, Visioli F, Raffin Pohlmann A, Figueiró F, Sonvico F, Stanisçuaski Guterres S. Bruinsmann FA, et al. Among authors: de fraga dias a. Int J Pharm. 2022 Mar 25;616:121563. doi: 10.1016/j.ijpharm.2022.121563. Epub 2022 Feb 10. Int J Pharm. 2022. PMID: 35151819
EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.
de Cristo Soares Alves A, Lavayen V, de Fraga Dias A, Bruinsmann FA, Scholl JN, Cé R, Visioli F, Oliveira Battastini AM, Stanisçuaski Guterres S, Figueiró F, Raffin Pohlmann A. de Cristo Soares Alves A, et al. Among authors: de fraga dias a. Nanomedicine (Lond). 2021 Aug;16(20):1775-1790. doi: 10.2217/nnm-2021-0169. Epub 2021 Jul 27. Nanomedicine (Lond). 2021. PMID: 34313137
Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth.
Lopes DV, de Fraga Dias A, Silva LFL, Scholl JN, Sévigny J, Battastini AMO, Figueiró F. Lopes DV, et al. Among authors: de fraga dias a. Purinergic Signal. 2021 Jun;17(2):273-284. doi: 10.1007/s11302-021-09775-w. Epub 2021 Mar 20. Purinergic Signal. 2021. PMID: 33745072 Free PMC article.
Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening.
Federico LB, Silva GM, de Fraga Dias A, Figueiró F, Battastini AMO, Dos Santos CBR, Costa LT, Rosa JMC, de Paula da Silva CHT. Federico LB, et al. Among authors: de fraga dias a. Int J Biol Macromol. 2020 Dec 15;165(Pt B):3040-3050. doi: 10.1016/j.ijbiomac.2020.10.136. Epub 2020 Oct 22. Int J Biol Macromol. 2020. PMID: 33736292
Acute moderate-intensity aerobic exercise promotes purinergic and inflammatory responses in sedentary, overweight and physically active subjects.
Moritz CEJ, Boeno FP, Vieira AF, Munhoz SV, Scholl JN, de Fraga Dias A, Pizzato PR, Figueiró F, Battastini AMO, Reischak-Oliveira A. Moritz CEJ, et al. Among authors: de fraga dias a. Exp Physiol. 2021 Apr;106(4):1024-1037. doi: 10.1113/EP089263. Epub 2021 Mar 8. Exp Physiol. 2021. PMID: 33624912 Free article.
15 results